newsfilter
← Latest News
Business Wire·

Medidata and Decibel Therapeutics Announce Multi-Year Collaboration in Support of Clinical Development for Hearing Loss, Tinnitus, and Balance Disorders

NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced that Decibel Therapeutics is adopting Medidata Cloud, the Intelligent Platform for Life Sciences. The agreement will support the Boston biotech company’s clinical development for hearing loss, tinnitus, and balance disorders.